A Bioinformatics Analysis to Evaluate the Prognostic Value of Stemness-related Genes in Gastric Cancer

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Feb 4

PMID 35116249

Authors

Yu-Jie Lu

Lian Lian

Xiao-Ming Shen

Ying Li

Sheng-Jun Ji

Wen-Jie Wang

Yi Yang

Ying Wang

Wei-Ming Duan

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to identify potential stemness-related targets in gastric cancer (GC) in order to support the development of new treatment strategies and improve patient survival.

Methods: Using the edgeR package, we identified stemness-related differentially expressed genes (DEGs) using GSE112631 and the stemness-related signaling pathways in the Gene Set Enrichment Analysis (GSEA) database. Lasso-penalized Cox regression analysis and multivariate Cox regression analysis tested by Akaike Information Criterion (AIC) were used to screen out survival genes in order to construct a prognostic model. We verified the accuracy of our prognostic model using a nomogram and receiver operating characteristic (ROC) curve analysis. Patients were divided into two groups based on the median risk score, and functional enrichment analysis was used to explore the differences between the two groups.

Results: Eight genes were selected to establish a prognostic model of The Cancer Genome Atlas (TCGA) and a validation model of the GSE84437 dataset from the Genome Expression Omnibus (GEO). In both models, we found that the low risk score group had better overall survival (OS) than the high-risk score group. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways between the two risk groups were totally different.

Conclusions: We used eight stemness-related genes to build a prognostic model. The high-risk score group had a worse prognosis compared to the low-risk score group.

Citing Articles

Zhu S, Zhang G, You Q, Li F, Ding B, Liu F Transl Cancer Res. 2022; 11(7):2359-2373.

PMID: 35966312 PMC: 9372233. DOI: 10.21037/tcr-22-1723.

References

Li K, Dan Z, Nie Y . Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment. World J Gastroenterol. 2014; 20(18):5420-6. PMC: 4017057. DOI: 10.3748/wjg.v20.i18.5420. View

Xu M, Gong A, Yang H, George S, Jiao Z, Huang H . Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44(+)/Musashi-1(+) gastric cancer stem cells. Cancer Lett. 2015; 369(1):124-33. DOI: 10.1016/j.canlet.2015.08.005. View

Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S, Clarke M . Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100(7):3983-8. PMC: 153034. DOI: 10.1073/pnas.0530291100. View

Singh S, Clarke I, Terasaki M, Bonn V, Hawkins C, Squire J . Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63(18):5821-8. View

Yong X, Tang B, Xiao Y, Xie R, Qin Y, Luo G . Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. Cancer Lett. 2016; 374(2):292-303. DOI: 10.1016/j.canlet.2016.02.032. View

Yan B, Yau E, Samanta S, Ong C, Yong K, Ng L . Clinical and therapeutic relevance of PIM1 kinase in gastric cancer. Gastric Cancer. 2011; 15(2):188-97. DOI: 10.1007/s10120-011-0097-2. View

Tian T, Zhang Y, Wang S, Zhou J, Xu S . Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer. J Biomed Res. 2013; 26(5):336-45. PMC: 3613730. DOI: 10.7555/JBR.26.20120045. View

Takaishi S, Okumura T, Wang T . Gastric cancer stem cells. J Clin Oncol. 2008; 26(17):2876-82. PMC: 2743304. DOI: 10.1200/JCO.2007.15.2603. View

Song X, Xin N, Wang W, Zhao C . Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis. Oncotarget. 2015; 6(34):35579-88. PMC: 4742126. DOI: 10.18632/oncotarget.5758. View

10.

Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

11.

Zhang X, Hua R, Wang X, Huang M, Gan L, Wu Z . Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer. Oncotarget. 2016; 7(9):9815-31. PMC: 4891086. DOI: 10.18632/oncotarget.6890. View

12.

Bandhavkar S . Cancer stem cells: a metastasizing menace!. Cancer Med. 2016; 5(4):649-55. PMC: 4831283. DOI: 10.1002/cam4.629. View

13.

Fan C, Chen T, Shang Y, Gu Y, Zhang S, Lu R . Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies. Cell Death Dis. 2013; 4:e828. PMC: 3824647. DOI: 10.1038/cddis.2013.337. View

14.

Takaishi S, Okumura T, Tu S, Wang S, Shibata W, Vigneshwaran R . Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009; 27(5):1006-20. PMC: 2746367. DOI: 10.1002/stem.30. View

15.

Takahashi T, Saikawa Y, Kitagawa Y . Gastric cancer: current status of diagnosis and treatment. Cancers (Basel). 2013; 5(1):48-63. PMC: 3730304. DOI: 10.3390/cancers5010048. View

16.

Xie Y, Bayakhmetov S . PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells. Mol Clin Oncol. 2016; 4(1):13-17. PMC: 4726986. DOI: 10.3892/mco.2015.673. View

17.

Wang Z, Zou F, Tian Y, Xiang B, Qin B, Liu Y . Paclitaxel reversed trastuzumab resistance via regulating JUN in human gastric cancer cells identified by FAN analysis. Future Oncol. 2018; 14(26):2701-2712. DOI: 10.2217/fon-2018-0127. View

18.

Jiang K, Liu H, Xie D, Xiao Q . Differentially expressed genes and are potential prognostic biomarkers for gastric cancer. Oncol Lett. 2019; 17(3):3191-3202. PMC: 6396260. DOI: 10.3892/ol.2019.9952. View

19.

Huang J, Bai Y, Huo L, Xiao J, Fan X, Yang Z . Upregulation of a disintegrin and metalloprotease 8 is associated with progression and prognosis of patients with gastric cancer. Transl Res. 2015; 166(6):602-13. DOI: 10.1016/j.trsl.2015.05.001. View

20.

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View